Kiniksa Pharmaceuticals International, plc (KNSA)

SEC filing

Kiniksa Pharmaceuticals International, plc

KNSA · CIK 1730430

4 · Sep 3, 2026 · CHIEF FINANCIAL OFFICER Ragosa Mark exercised options for 18.21K shares; was granted 38.95K shares; reported 4,404 Class A Ordinary Share

CHIEF FINANCIAL OFFICER Ragosa Mark exercised options for 18.21K shares; was granted 38.95K shares; reported 4,404 Class A Ordinary Share

Filed: Sep 3, 2026
Period: Sep 1, 2026
Accession: 0001835458-26-000012
Filer: Kiniksa Pharmaceuticals International, plc

View on SEC.gov All SEC filings

Filing document

xslF345X06/form4-09032026_080953.xml

xslF345X06/form4-09032026_080953.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4form4-09032026_080953.xml
Open SEC.gov